Ask AI

Personalized Treatment in EGFR-Mutated NSCLC: Applying the Latest Clinical Evidence to Address Barriers and Improve Quality of Care

Gain expert insights into the latest clinical data on EGFR-mutated NSCLC to guide treatment selection and improve patient outcomes and quality of life through a certified on-demand webcast, ClinicalThought commentary, and downloadable slides.

Share

Program Content

Activities

Pharmacy Updates 1L Treatment for EGFRm NSCLC
Pharmacy Updates and the Evolving First-Line Treatment Landscape for Patients With EGFR-Mutated NSCLC 
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2025

Provided by

ProCE Banner

Provided by ProCE, LLC In partnership with Clinical Care Options, LLC

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Partners

Clinical Care Options, LLC

ProCE Banner